Agios Pharmaceuticals Inc (AGIO)
33.03
+0.09
(+0.27%)
USD |
NASDAQ |
May 10, 16:00
33.03
0.00 (0.00%)
After-Hours: 20:00
Agios Pharmaceuticals 1 Year Total Returns (Daily): 29.68% for May 9, 2024
1 Year Total Returns (Daily) Chart
Historical 1 Year Total Returns (Daily) Data
| Date | Value |
|---|---|
| May 09, 2024 | 29.68% |
| May 08, 2024 | 27.74% |
| May 07, 2024 | 28.43% |
| May 06, 2024 | 30.07% |
| May 03, 2024 | 51.03% |
| May 02, 2024 | 52.81% |
| May 01, 2024 | 45.15% |
| April 30, 2024 | 42.11% |
| April 29, 2024 | 43.24% |
| April 26, 2024 | 42.49% |
| April 25, 2024 | 41.13% |
| April 24, 2024 | 40.69% |
| April 23, 2024 | 40.26% |
| April 22, 2024 | 33.20% |
| April 19, 2024 | 28.78% |
| April 18, 2024 | 30.86% |
| April 17, 2024 | 28.85% |
| April 16, 2024 | 31.27% |
| April 15, 2024 | 33.36% |
| April 12, 2024 | 38.03% |
| April 11, 2024 | 39.61% |
| April 10, 2024 | 38.68% |
| April 09, 2024 | 36.47% |
| April 08, 2024 | 27.24% |
| April 05, 2024 | 27.19% |
| Date | Value |
|---|---|
| April 04, 2024 | 29.26% |
| April 03, 2024 | 25.42% |
| April 02, 2024 | 24.82% |
| April 01, 2024 | 25.64% |
| March 28, 2024 | 29.67% |
| March 27, 2024 | 30.88% |
| March 26, 2024 | 33.67% |
| March 25, 2024 | 36.52% |
| March 22, 2024 | 37.13% |
| March 21, 2024 | 30.80% |
| March 20, 2024 | 33.00% |
| March 19, 2024 | 29.36% |
| March 18, 2024 | 25.92% |
| March 15, 2024 | 26.70% |
| March 14, 2024 | 28.93% |
| March 13, 2024 | 32.63% |
| March 12, 2024 | 37.87% |
| March 11, 2024 | 40.19% |
| March 08, 2024 | 32.92% |
| March 07, 2024 | 33.15% |
| March 06, 2024 | 31.53% |
| March 05, 2024 | 28.36% |
| March 04, 2024 | 31.63% |
| March 01, 2024 | 29.03% |
| February 29, 2024 | 27.70% |
Total Return Definition
The Total return is the change in price over a specific period of time that includes dividends and distributions paid.
1 Year Total Returns (Daily) Range, Past 5 Years
-70.84%
Minimum
Jun 16 2022
59.31%
Maximum
Mar 17 2021
-12.49%
Average
-12.71%
Median
1 Year Total Returns (Daily) Benchmarks
| Alnylam Pharmaceuticals Inc | -27.17% |
| Amgen Inc | 37.93% |
| Blueprint Medicines Corp | 100.1% |
| Corcept Therapeutics Inc | 11.75% |
| Ionis Pharmaceuticals Inc | 10.56% |